Clinical Trial Update: A Study to Learn About the Study Medicine Called Infliximab (Genetical Recombination)[Infliximab Biosimilar 3] in People With Rheumatoid Arthritis, Ulcerative Colitis, Crohn's Disease, or Psoriasis

View source ↗

Summary

Pfizer-sponsored trial of infliximab biosimilar 3 in rheumatoid arthritis, ulcerative colitis, Crohn's disease, and psoriasis has completed with results posted …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Crohn Disease
• Psoriasis
• Rheumatoid Arthritis
• Ulcerative Colitis

Drugs mentioned

• Infliximab Biosimilar 3 (infliximab biosimilar 3)

Snippet

Sponsor: Pfizer | Conditions: Arthritis, Rheumatoid, Colitis, Ulcerative | Status: COMPLETED | Results posted: 2025-06-04